Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas.

Liu AK, Macy ME, Foreman NK.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1148-54. doi: 10.1016/j.ijrobp.2008.12.032.

2.

Bevacizumab as a treatment option for radiation-induced cerebral necrosis.

Matuschek C, Bölke E, Nawatny J, Hoffmann TK, Peiper M, Orth K, Gerber PA, Rusnak E, Lammering G, Budach W.

Strahlenther Onkol. 2011 Feb;187(2):135-9. doi: 10.1007/s00066-010-2184-4. Epub 2011 Jan 24. Review.

PMID:
21336713
3.

Bevacizumab for radiation necrosis following treatment of high grade glioma: a systematic review of the literature.

Lubelski D, Abdullah KG, Weil RJ, Marko NF.

J Neurooncol. 2013 Dec;115(3):317-22. doi: 10.1007/s11060-013-1233-0. Epub 2013 Sep 5. Review.

PMID:
24005770
4.

Drug review: Safety and efficacy of bevacizumab for glioblastoma and other brain tumors.

Narita Y.

Jpn J Clin Oncol. 2013 Jun;43(6):587-95. doi: 10.1093/jjco/hyt051. Epub 2013 Apr 12. Review.

5.

Challenges with the diagnosis and treatment of cerebral radiation necrosis.

Chao ST, Ahluwalia MS, Barnett GH, Stevens GH, Murphy ES, Stockham AL, Shiue K, Suh JH.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):449-57. doi: 10.1016/j.ijrobp.2013.05.015. Epub 2013 Jun 19. Review.

PMID:
23790775
6.

Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities.

Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD.

J Neurooncol. 2009 Oct;95(1):1-11. doi: 10.1007/s11060-009-9897-1. Epub 2009 Apr 21. Review.

PMID:
19381441
7.
8.

Pediatric glial tumors.

Cohen KJ, Broniscer A, Glod J.

Curr Treat Options Oncol. 2001 Dec;2(6):529-36. Review.

PMID:
12057098
9.

Stereotactic radiosurgery for intracranial gliomas.

Tanaka S, Shin M, Mukasa A, Hanakita S, Saito K, Koga T, Saito N.

Neurosurg Clin N Am. 2013 Oct;24(4):605-12. doi: 10.1016/j.nec.2013.05.010. Epub 2013 Aug 2. Review.

PMID:
24093578
10.

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas.

Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ.

Lancet Oncol. 2008 May;9(5):453-61. doi: 10.1016/S1470-2045(08)70125-6. Review.

PMID:
18452856
11.

Reirradiation tolerance of the human brain.

Mayer R, Sminia P.

Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1350-60. Epub 2007 Nov 26. Review.

PMID:
18037587
12.

Delayed brain radiation necrosis: pathological review and new molecular targets for treatment.

Furuse M, Nonoguchi N, Kawabata S, Miyatake S, Kuroiwa T.

Med Mol Morphol. 2015 Dec;48(4):183-90. Review.

PMID:
26462915
13.

Bevacizumab in the treatment of high-grade gliomas: an overview.

Kunnakkat S, Narayana A.

Angiogenesis. 2011 Dec;14(4):423-30. doi: 10.1007/s10456-011-9232-2. Epub 2011 Aug 21. Review.

PMID:
21858651
14.

Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas.

de Groot JF, Yung WK.

Cancer J. 2008 Sep-Oct;14(5):279-85. doi: 10.1097/PPO.0b013e3181867bd6. Review.

PMID:
18836331
15.

Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations.

Rahmathulla G, Marko NF, Weil RJ.

J Clin Neurosci. 2013 Apr;20(4):485-502. doi: 10.1016/j.jocn.2012.09.011. Epub 2013 Feb 14. Review.

PMID:
23416129
16.

Current and future strategies in radiotherapy of childhood low-grade glioma of the brain. Part I: Treatment modalities of radiation therapy.

Kortmann RD, Timmermann B, Taylor RE, Scarzello G, Plasswilm L, Paulsen F, Jeremic B, Gnekow AK, Dieckmann K, Kay S, Bamberg M.

Strahlenther Onkol. 2003 Aug;179(8):509-20. Review.

PMID:
14509949
17.

Emerging clinical principles on the use of bevacizumab for the treatment of malignant gliomas.

Chamberlain MC.

Cancer. 2010 Sep 1;116(17):3988-99. doi: 10.1002/cncr.25256. Review.

18.

Radiation necrosis following treatment of high grade glioma--a review of the literature and current understanding.

Siu A, Wind JJ, Iorgulescu JB, Chan TA, Yamada Y, Sherman JH.

Acta Neurochir (Wien). 2012 Feb;154(2):191-201; discussion 201. doi: 10.1007/s00701-011-1228-6. Epub 2011 Dec 1. Review.

PMID:
22130634
19.

The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence.

Parvez K, Parvez A, Zadeh G.

Int J Mol Sci. 2014 Jul 3;15(7):11832-46. doi: 10.3390/ijms150711832. Review.

20.

Neurocognitive Deficits After Radiation Therapy for Brain Malignancies.

Saad S, Wang TJ.

Am J Clin Oncol. 2015 Dec;38(6):634-40. doi: 10.1097/COC.0000000000000158. Review.

PMID:
25503433
Items per page

Supplemental Content

Write to the Help Desk